Abstract
In this study, we describe the synthesis of a host‐guest supramolecule (TDPAnβ‐CD) formed from an anthracene‐based conjugated molecule (TDPAn, guest) encapsulated in cyclodextrin (β‐CD, host) under microwave irradiation. The obtaining of the desired rotaxane was confirmed by different spectroscopic and thermal analyzes. A comparative study between the physicochemical and electrical properties of the free molecule (TDPAn) and those of the rotaxane (TDPAnβ‐CD) was conducted. Thermal analyzes show an amorphous morphology and good thermal stability for the rotaxane. The surface morphology of the synthesized materials was studied using atomic force microscopy and contact angle measurement. The supramolecular film exhibits a smooth and homogeneous surface with a relatively low surface roughness compared to that of the free model. The absorption and photoluminescence spectra of the rotaxane thin film are blue‐shifted in comparison with TDPAn, due to a steric hindrance effect of the β‐CD. Hence, a blue intense photoluminescence was emitted from the rotaxane layer, compared to a violet‐red emission in the case of non‐encapsulated TDPAn. Higher electron affinity and ionization potential for the host‐guest supramolecule were observed by cyclic voltammetry. The static study of ITO/TDPAn/Al and ITO/TDPAnβ‐CD/Al schottky single layer diodes showed typical behaviors with relatively low threshold voltages and higher charge carrier mobility was achieved for the rotaxane active layer.
Anthracene‐based semiconducting molecule (TDPAn) encapsulated by cyclodextrin (TDPAnβ‐CD) was synthesized under microwave irradiation. The supramolecular film exhibits good thermal stability and a smooth and homogeneous surface with a relatively lower surface roughness compared to that of the free model (TDPAn). The fluorescence spectrum of TDPAnβ‐CD undergoes an hypsochromic displacement and its emission efficiency is improved compared to the free model. The static study showed a relatively low threshold voltages and higher charge carrier mobility in the case of the rotaxane.